Press "Enter" to skip to content

Bayer profit flat as weak animal health offsets strong Xarelto

Bayer’s best-selling stroke prevention drug Xarelto contributed to the positive surprise with a better-than-expected 933 million euros in quarterly sales, helped by a wider range of health conditions for which the pill can be prescribed.

Original source:

Also Read:   SeQuent Scientific launches Citramox LA injection in 10 European countries